Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early
NCT04398004
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Virus Diseases
Corona Virus Infection
Interventions
DRUG:
Clarithromycin
Sponsor
Hellenic Institute for the Study of Sepsis